Heterozygous null mutations in POMC and loss-of-function mutations in α- and β-melanocyte-stimulating hormone (α- and β-MSH) significantly increase obesity risk but are not invariably associated with obesity (Coll et al. 2004). This evidence concerns the gene POMC and obesity due to melanocortin 4 receptor deficiency.